DEF 14A: Nanophase Technologies Seeks Stockholder Approval to Increase Authorized Shares Amid Financing Agreement

Nanophase Technologies is asking stockholders to approve an amendment to its Certificate of Incorporation to increase the number of authorized common stock shares from 60,000,000 to 95,000,000, primarily to facilitate the conversion of preferred stock issued to Strandler, LLC.

Summary

• Nanophase Technologies is holding a Special Meeting of Stockholders on June 18, 2024, to vote on a proposal to amend the company's Certificate of Incorporation.
• The primary purpose of the amendment is to increase the number of authorized shares of common stock from 60,000,000 to 95,000,000.
• This increase is required under a Securities Purchase Agreement with Strandler, LLC, an entity controlled by the company's controlling shareholder, to allow for the conversion of 15,000 shares of Series X Preferred Stock into 15,000,000 shares of common stock.
• As of May 17, 2024, Nanophase had 54,860,984 shares of common stock outstanding.
• The Board of Directors recommends that stockholders vote FOR the amendment.
• The company may also explore entering into other convertible note or equity-linked transactions to provide liquidity.

Sentiment

Score: 4

Explanation: The document is primarily factual, but the need for increased authorized shares to facilitate a related-party financing agreement and the resulting dilution are negative signals. The company's reliance on its controlling shareholder for financing is also a concern.

Positives

• The proposed amendment provides the company with the flexibility to issue common stock or securities convertible into common stock if an attractive opportunity arises.
• The company believes that the transaction with Strandler, LLC, was in the best interests of the company to provide necessary financing to fund the company's operations.

Negatives

• Approval of the amendment will result in immediate dilution for existing shareholders upon conversion of the Series X Preferred Stock.
• The company has previously failed to obtain financing on acceptable terms from any sources other than its controlling stockholder.
• An increase in the number of authorized shares of common stock may also, under certain circumstances, be construed as having an anti-takeover effect.

Risks

• If the company issues additional shares of common stock, the ownership interests of holders of our common stock will be diluted.
• If the company issues additional shares of preferred stock, the shares may have rights, preferences, and privileges senior to those of its common stock.
• The authority of our Board to issue common stock might be used to create voting impediments or to frustrate an attempt by another person or entity to effect a takeover or otherwise gain control of us because the issuance of additional shares of common stock would dilute the voting power of the common stock then outstanding.

Future Outlook

The Amendment is also intended to give the Company flexibility to issue common stock or securities convertible into common stock if an attractive opportunity to do so arises. In the future, the Company may also explore the possibility of entering into one or more other convertible note or other equity-linked transactions to provide liquidity to allow it to continue to pursue its current business plan.

Management Comments

• The Board of Directors recommends a vote FOR the amendment to increase the number of authorized shares of common stock.

Industry Context

Many companies periodically increase their authorized share count to provide flexibility for future financing, acquisitions, or employee equity plans. This move by Nanophase is driven by a specific financing agreement with its controlling shareholder.

Comparison to Industry Standards

• Increasing authorized shares is a common practice among publicly traded companies to provide flexibility for future capital raises, acquisitions, or stock-based compensation plans.
• Comparable companies in the materials science or nanotechnology sectors, such as Altair Nanotechnologies or US Nanocorp, may also periodically seek shareholder approval for similar increases in authorized shares to support their growth strategies.

Related Party Transactions

• The company entered into a Securities Purchase Agreement with Strandler, LLC, an entity controlled by the company's controlling shareholder (who is the brother of R. Janet Whitmore, the chair of our Board), to allow for the conversion of the 15,000 shares of Series X Preferred Stock sold pursuant to the Purchase Agreement.

Stakeholder Impact

• Existing shareholders will experience dilution upon conversion of the Series X Preferred Stock.
• The increased authorized shares provide the company with greater flexibility for future financing, which could benefit the company and its stakeholders in the long term.

Next Steps

• Stockholders will vote on the proposed amendment at the Special Meeting on June 18, 2024.
• If approved, the company will file a certificate of amendment to its Certificate of Incorporation with the Secretary of State of Delaware.
• Strandler, LLC, is expected to exercise its conversion rights under the Purchase Agreement upon approval of the amendment.
• The company may explore additional financing options, including convertible notes or equity-linked transactions.

Key Dates

Keywords

authorized shares, common stock, proxy statement, Nanophase Technologies, Strandler LLC, Series X Preferred Stock, dilution, financing, amendment, conversion